2g69: Difference between revisions

Revision as of 06:06, 29 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2g69.png

Template:STRUCTURE 2g69

Structure of Unliganded HIV-1 Protease F53L MutantStructure of Unliganded HIV-1 Protease F53L Mutant

Template:ABSTRACT PUBMED 16569415

About this StructureAbout this Structure

2G69 is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

ReferenceReference

Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation., Liu F, Kovalevsky AY, Louis JM, Boross PI, Wang YF, Harrison RW, Weber IT, J Mol Biol. 2006 May 19;358(5):1191-9. Epub 2006 Mar 20. PMID:16569415

Page seeded by OCA on Tue Jul 29 06:06:19 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2g69.gif|left|200px]]
+{{Seed}}
+[[Image:2g69.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2g69|  PDB=2g69  |  SCENE=  }}
-'''Structure of Unliganded HIV-1 Protease F53L Mutant'''
+===Structure of Unliganded HIV-1 Protease F53L Mutant===
-==Overview==
+<!--
-Mutations in HIV-1 protease (PR) that produce resistance to antiviral PR inhibitors are a major problem in AIDS therapy. The mutation F53L arising from antiretroviral therapy was introduced into the flexible flap region of the wild-type PR to study its effect and potential role in developing drug resistance. Compared to wild-type PR, PR(F53L) showed lower (15%) catalytic efficiency, 20-fold weaker inhibition by the clinical drug indinavir, and reduced dimer stability, while the inhibition constants of two peptide analog inhibitors were slightly lower than those for PR. The crystal structure of PR(F53L) was determined in the unliganded form at 1.35 Angstrom resolution in space group P4(1)2(1)2. The tips of the flaps in PR(F53L) had a wider separation than in unliganded wild-type PR, probably due to the absence of hydrophobic interactions of the side-chains of Phe53 and Ile50'. The changes in interactions between the flaps agreed with the reduced stability of PR(F53L) relative to wild-type PR. The altered flap interactions in the unliganded form of PR(F53L) suggest a distinct mechanism for drug resistance, which has not been observed in other common drug-resistant mutants.
+The line below this paragraph, {{ABSTRACT_PUBMED_16569415}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 16569415 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_16569415}}
 ==About this Structure==
@@ Line 30: / Line 34: @@
 [[Category: Non-active site mutant]]
 [[Category: Unliganded]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 04:44:05 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 06:06:19 2008''